Growth Metrics

Eli Lilly (LLY) FCF Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -7.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -537.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -911.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 1,568.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 534.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 913.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 9,115.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -1,716.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.00
Dec 31, 2025 -1,240.00
Sep 30, 2025 1,530.00
Jun 30, 2025 -359.00
Mar 31, 2025 -2,640.00
Dec 31, 2024 -1,740.00
Sep 30, 2024 153.00
Jun 30, 2024 -1,855.00
Mar 31, 2024 -1,848.00
Dec 31, 2023 -3,307.00
Sep 30, 2023 -1,179.00
Jun 30, 2023 -4,153.00
Mar 31, 2023 1,314.00
Dec 31, 2022 -1,086.00
Sep 30, 2022 28.00
Jun 30, 2022 -187.00
Mar 31, 2022 2,551.00
Dec 31, 2021 593.00
Sep 30, 2021 -1,578.00
Jun 30, 2021 -94.00
Mar 31, 2021 1,650.00
Dec 31, 2020 -282.00
Sep 30, 2020 -433.00
Jun 30, 2020 1,571.00
Mar 31, 2020 -115.00
Dec 31, 2019 -94.00
Sep 30, 2019 -486.00
Jun 30, 2019 -701.00
Mar 31, 2019 979.00
Dec 31, 2018 725.00
Sep 30, 2018 1,814.00
Jun 30, 2018 706.00
Mar 31, 2018 992.00
Dec 31, 2017 95.00
Sep 30, 2017 36.00
Jun 30, 2017 836.00
Mar 31, 2017 177.00
Dec 31, 2016 598.00
Sep 30, 2016 -248.00
Jun 30, 2016 -391.00
Mar 31, 2016 -1,163.00
Dec 31, 2015 -850.00
Sep 30, 2015 -827.00
Jun 30, 2015 -556.00
Mar 31, 2015 -1,877.00
Dec 31, 2014 -778.00
Sep 30, 2014 -227.00
Jun 30, 2014 -1,422.00
Mar 31, 2014 -1,690.00
Dec 31, 2013 -1,022.00
Sep 30, 2013 103.00
Jun 30, 2013 -613.00
Mar 31, 2013 -1,123.00
Dec 31, 2012 -973.00
Sep 30, 2012 402.00
Jun 30, 2012 601.00
Mar 31, 2012 1,425.00